Right- and left-sided colorectal cancers respond differently to cetuximab

INTRODUCTION: Right-sided colon cancer (RSCC) and left-sided colorectal cancer (LSCRC) differ with respect to their biology and genomic patterns. This study aimed to examine whether the primary tumor location is associated with the response to cetuximab in patients with metastatic colorectal cancer...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chin J Cancer
Hlavní autoři: Wang, Feng, Bai, Long, Liu, Tian-Shu, Yu, Yi-Yi, He, Ming-Ming, Liu, Kai-Yan, Luo, Hui-Yan, Zhang, Dong-Sheng, Jin, Yin, Wang, Feng-Hua, Wang, Zhi-Qiang, Wang, De-Shen, Qiu, Miao-Zhen, Ren, Chao, Li, Yu-Hong, Xu, Rui-Hua
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593341/
https://ncbi.nlm.nih.gov/pubmed/26111811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0022-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky